Reconstitution of B cells after B cell-depletion therapy: Comment on the article by Leandro et al.
Teng
Yoe Kie Onno
YK
van Tilborg
Aukje
A
van Laar
Jacob M
JM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D018655:Lymphocyte Count; D008212:Lymphocyte Depletion; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab